You are here: Industry Insights > COVID-19

News List

Regeneron says COVID-19 antibody cocktail may be available by fall expresspharma
May 06, 2020
The company is one of the many drugmakers looking to tackle COVID-19, caused by the new coronavirus that has no current approved treatment or vaccine and has claimed over 250,000 lives worldwide.
Ajinomoto Bio-Pharma Services announces manufacturing partnership with CytoDyn for drug product used expresspharma
May 06, 2020
The company provides high-quality drug product aseptic fill finish services for CytoDyn.
Health Ministry asks AIOCD to ensure availability of critical drugs for management of COVID-19 expresspharma
May 06, 2020
The ministry has forwarded a list of 55 drugs for ICU management of novel coronavirus patients and a list of another 96 drugs for general availability and treatment of various co-morbid conditions.
Eli Lilly, Junshi collaborate to develop antibody therapies for Covid-19 disease pharmaceutical-business-review
May 05, 2020
Eli Lilly has collaborated with Junshi Biosciences for the development of therapeutic antibodies to treat and prevent Covid-19, the disease resulted due to the SARS-CoV-2 novel coronavirus.
NICE publishes latest set of COVID-19 guidelines pharmatimes
May 05, 2020
The National Institute for Health and Care Excellence (NICE) has published its latest set of rapid coronavirus guidelines, for the care of immunocompromised people under 17 years old and adults hospitalised with pneumonia.
Canada provides $175.6m for AbCellera to develop Covid-19 therapies pharmaceutical-technology
May 05, 2020
The Canadian government has agreed to provide up to $175.6m to support AbCellera in the development of antibody-based therapies against Covid-19.
Researchers identify antibody with activity against SARS-CoV-2 in lab pharmaceutical-technology
May 05, 2020
Researchers at Utrecht University and Erasmus Medical Center in the Netherlands, in alliance with China-based firm Harbour BioMed, have identified a fully human monoclonal antibody with activity against the novel coronavirus, SARS-CoV-2.
Premas Biotech announces development of vaccine against COVID-19 expresspharma
May 05, 2020
The triple antigen vaccine being developed by Premas Biotech is being designed to try to overcome presently known and possible future mutations of novel coronavirus.
US FDA gives EUA to Roche for COVID-19 antibody test expresspharma
May 05, 2020
The company aims to more than double production of tests from about 50 million a month to significantly more than 100 million a month by the end of the year.
AIOCD requests PM to provide medical insurance to chemists, willing to pay a partial sum of premium expresspharma
May 05, 2020
Around 12-14 chemists from across the country have been found COVID-19 positive of which two of them have died.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page